UPDF AI

HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia

R. Hamers,M. Siwale,7 Authors,T. F. Rinke de Wit

2010 · DOI: 10.1097/QAI.0b013e3181e544e0
Journal of Acquired Immune Deficiency Syndromes · 46 Citations

TLDR

Baseline resistance may compromise the response to standard NNRTI-based first-line ART in 6% of patients in Lusaka, Zambia, and continuous resistance monitoring is warranted to maintain individual and population-level ART effectiveness.